Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Return on Invested Capital (2023 - 2025)

Arcturus Therapeutics Holdings' Return on Invested Capital history spans 3 years, with the latest figure at 0.31% for Q2 2025.

  • For Q2 2025, Return on Invested Capital rose 4.0% year-over-year to 0.31%; the TTM value through Jun 2025 reached 0.31%, up 4.0%, while the annual FY2024 figure was 0.37%, 9.0% down from the prior year.
  • Return on Invested Capital reached 0.31% in Q2 2025 per ARCT's latest filing, up from 0.34% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.21% in Q3 2023 to a low of 0.46% in Q1 2024.
  • Average Return on Invested Capital over 3 years is 0.28%, with a median of 0.33% recorded in 2025.
  • Peak YoY movement for Return on Invested Capital: plummeted -52bps in 2024, then increased 12bps in 2025.
  • A 3-year view of Return on Invested Capital shows it stood at 0.3% in 2023, then dropped by -28bps to 0.38% in 2024, then rose by 18bps to 0.31% in 2025.
  • Per Business Quant, the three most recent readings for ARCT's Return on Invested Capital are 0.31% (Q2 2025), 0.34% (Q1 2025), and 0.38% (Q4 2024).